Similar articles

• A safety and pharmacokinetic trial assessing delivery of dapivirine from a vaginal ring in healthy women.

  Nel A, Haazen W, Nuttall J, Romano J, Rosenberg Z, van Niekerk N. Nel A, et al. AIDS. 2014 Jun 19;28(10):1479-87. doi: 10.1097/QAD.0000000000000280. AIDS. 2014. PMID: 24901365 Clinical Trial.
• Pre-clinical development of a combination microbicide vaginal ring containing dapivirine and darunavir.

  Murphy DJ, Desjardins D, Dereuddre-Bosquet N, Brochard P, Perrot L, Pruvost A, Le Grand R, Lagatie O, Vanhooren L, Feyaerts M, van Roey J, Malcolm RK. Murphy DJ, et al. J Antimicrob Chemother. 2014 Sep;69(9):2477-88. doi: 10.1093/jac/dku160. Epub 2014 May 26. J Antimicrob Chemother. 2014. PMID: 24862093
• Post-use assay of vaginal rings (VRs) as a potential measure of clinical trial adherence.

  Spence P, Nel A, van Niekerk N, Derrick T, Wilder S, Devlin B. Spence P, et al. J Pharm Biomed Anal. 2016 Jun 5;125:94-100. doi: 10.1016/j.jpba.2016.03.023. Epub 2016 Mar 14. J Pharm Biomed Anal. 2016. PMID: 27016673 Free PMC article.
• Development of dapivirine vaginal ring for HIV prevention.

  Devlin B, Nuttall J, Wilder S, Woodsong C, Rosenberg Z. Devlin B, et al. Antiviral Res. 2013 Dec;100 Suppl:S3-8. doi: 10.1016/j.antiviral.2013.09.025. Epub 2013 Nov 1. Antiviral Res. 2013. PMID: 24188702 Review.
• Assessment of topical microbicides to prevent HIV-1 transmission: concepts, testing, lessons learned.

  Friend DR, Kiser PF. Friend DR, et al. Antiviral Res. 2013 Sep;99(3):391-400. doi: 10.1016/j.antiviral.2013.06.021. Epub 2013 Jul 8. Antiviral Res. 2013. PMID: 23845918 Review.